Strides Pharma Q1 net loss at Rs 4 crore Ruby Khatun Khatun9 Aug 2018 10:15 AM ISTNew Delhi: Strides Pharma Science reported a consolidated net loss of Rs 4.16 crore for the quarter ended June 30.The company had posted a net profit...
Two-week training programme on herbal drugs starts at NIPER Ruby Khatun Khatun9 Aug 2018 10:00 AM ISTMohali: A two-week-long intensive training programme on trends and challenges in regulation and standardization of herbal drugs and formulations...
AstraZeneca settles Texas drug lawsuits for 110 million dollar Ruby Khatun Khatun9 Aug 2018 9:45 AM ISTLONDON: Drugmaker AstraZeneca has agreed to pay $110 million to settle two lawsuits brought by the state of Texas claiming that it fraudulently...
China orders recall from overseas as vaccine scandal churns Ruby Khatun Khatun9 Aug 2018 9:30 AM ISTBEIJING: China's National Health Commission says investigators have begun recalling defective vaccines produced by a Chinese drugmaker from domestic...
Cipla gets USFDA approval for osteoarthritis of joint pain relief gel Ruby Khatun Khatun8 Aug 2018 10:45 AM ISTNew Delhi: Drug major Cipla said it has received final approval from the United States Food and Drug Administration (USFDA) for Diclofenac Sodium...
Unichem Labs gets 4 observations from USFDA for Roha facility Ruby Khatun Khatun8 Aug 2018 10:30 AM ISTNew Delhi: Drug firm Unichem Laboratories said the US health regulator has made four observations after inspection of its active pharmaceutical...
Regeneron to invest 100 million dollar in bluebird, jointly develop cancer therapies Ruby Khatun Khatun8 Aug 2018 10:00 AM ISTRegeneron Pharmaceuticals Inc said it will invest $100 million in cancer drug developer bluebird bio Inc, and the companies will jointly develop new...
Novo Nordisk expects lower US prices next year Ruby Khatun Khatun8 Aug 2018 9:45 AM ISTCOPENHAGEN: Novo Nordisk, the world’s top maker of diabetes drugs, on Wednesday reported second-quarter operating profit broadly in line with...
Scandal-hit Chinese vaccine maker Changsheng started falsifying records in 2014: Report Ruby Khatun Khatun8 Aug 2018 9:30 AM ISTSHANGHAI: Changsheng Biotechnology Co Ltd, a vaccine maker at the center of a safety scandal in China, began falsifying production records for its...
Sanofi launches multiple sclerosis drug in India Ruby Khatun Khatun7 Aug 2018 10:30 AM ISTAubagio® offers patients diagnosed with Multiple Sclerosis the efficacy and convenience of once-a-day oral treatmentOver 200,000 people in India are...
Alembic Pharma gets tentative USFDA approval for ophthalmic solution Ruby Khatun Khatun7 Aug 2018 10:15 AM ISTNew Delhi: Drug firm Alembic Pharmaceuticals has received tentative approval from the US Food and Drug Administration (USFDA) for Bimatoprost...
Glenmark signs licence deal with Harbour BioMed to commercialise cancer antibody in Greater China Ruby Khatun Khatun7 Aug 2018 10:00 AM ISTNew Delhi: Glenmark Pharmaceuticals and biopharmaceutical firm Harbour BioMed have entered into an exclusive license agreement to develop, manufacture...
